de Oliveira Silva B, Severina do Monte Z, Santos Costa E, Silva R, Souza N, Barros Menezes R
Future Med Chem. 2024; 16(18):1839-1852.
PMID: 39235081
PMC: 11486029.
DOI: 10.1080/17568919.2024.2385887.
Opperman T, Dhingra S, Gutierrez-Perez C, Kwasny S, Cramer R
Methods Mol Biol. 2023; 2658:17-34.
PMID: 37024692
DOI: 10.1007/978-1-0716-3155-3_2.
Gebremariam T, Alkhazraji S, Alqarihi A, Jeon H, Gu Y, Kapoor M
Antimicrob Agents Chemother. 2018; 63(2).
PMID: 30455236
PMC: 6355556.
DOI: 10.1128/AAC.01713-18.
Shaw K, Schell W, Covel J, Duboc G, Giamberardino C, Kapoor M
Antimicrob Agents Chemother. 2018; 62(8).
PMID: 29891599
PMC: 6105804.
DOI: 10.1128/AAC.00523-18.
Agun S, Fernandez L, Gonzalez-Menendez E, Martinez B, Rodriguez A, Garcia P
Viruses. 2018; 10(3).
PMID: 29495568
PMC: 5869496.
DOI: 10.3390/v10030103.
Potentiation of the activity of β-lactam antibiotics by farnesol and its derivatives.
Kim C, Hesek D, Lee M, Mobashery S
Bioorg Med Chem Lett. 2018; 28(4):642-645.
PMID: 29402738
PMC: 5817034.
DOI: 10.1016/j.bmcl.2018.01.028.
Low-level predation by lytic phage phiIPLA-RODI promotes biofilm formation and triggers the stringent response in Staphylococcus aureus.
Fernandez L, Gonzalez S, Campelo A, Martinez B, Rodriguez A, Garcia P
Sci Rep. 2017; 7:40965.
PMID: 28102347
PMC: 5244418.
DOI: 10.1038/srep40965.
An in vitro synergistic interaction of combinations of Thymus glabrescens essential oil and its main constituents with chloramphenicol.
Ilic B, Kocic B, Ciric V, Cvetkovic O, Miladinovic D
ScientificWorldJournal. 2014; 2014:826219.
PMID: 24616649
PMC: 3926437.
DOI: 10.1155/2014/826219.
Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS.
Fernandez L, Gooderham W, Bains M, McPhee J, Wiegand I, Hancock R
Antimicrob Agents Chemother. 2010; 54(8):3372-82.
PMID: 20547815
PMC: 2916309.
DOI: 10.1128/AAC.00242-10.
Critical influence of resistance to streptogramin B-type antibiotics on activity of RP 59500 (quinupristin-dalfopristin) in experimental endocarditis due to Staphylococcus aureus.
Fantin B, Leclercq R, Merle Y, Veyrat C, Duval J, Carbon C
Antimicrob Agents Chemother. 1995; 39(2):400-5.
PMID: 7726505
PMC: 162550.
DOI: 10.1128/AAC.39.2.400.
Combined effect of amphotericin B and rifampin on Candida species.
Edwards Jr J, Morrison J, Henderson D, Montgomerie J
Antimicrob Agents Chemother. 1980; 17(3):484-7.
PMID: 7425608
PMC: 283814.
DOI: 10.1128/AAC.17.3.484.
Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.
Odds F
Antimicrob Agents Chemother. 1982; 22(5):763-70.
PMID: 6295266
PMC: 185657.
DOI: 10.1128/AAC.22.5.763.
Serum bactericidal activity against Enterobacteriaceae producing broad-spectrum beta-lactamases in volunteers administered ofloxacin and cefotaxime, alone or combined.
Weber P, Boussougant Y, Farinotti R, Carbon C
Eur J Clin Microbiol Infect Dis. 1989; 8(6):524-6.
PMID: 2504593
DOI: 10.1007/BF01967472.
Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase.
Fantin B, Pangon B, Potel G, Caron F, Vallee E, Vallois J
Antimicrob Agents Chemother. 1990; 34(4):581-6.
PMID: 2188586
PMC: 171647.
DOI: 10.1128/AAC.34.4.581.
Piperacillin, tazobactam, and gentamicin alone or combined in an endocarditis model of infection by a TEM-3-producing strain of Klebsiella pneumoniae or its susceptible variant.
Mentec H, Vallois J, Bure A, Saleh-Mghir A, Jehl F, Carbon C
Antimicrob Agents Chemother. 1992; 36(9):1883-9.
PMID: 1329634
PMC: 192204.
DOI: 10.1128/AAC.36.9.1883.